🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

30,79 USD

Máx. histórico

61,25

1784 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-49,73%

Rango 52 semanas

23,62 – 31,06

Variación hoy

+2,63%

Cierre anterior

30,00

Rango de hoy

30,04 – 30,90

Volumen hoy

48.251.619

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,61 (puede no estar actualizado)
Dividend yield
5,73% (puede no estar actualizado)
Precio objetivo analistas
29,45 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 18 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,59%
Fecha de pago Importe por participación
24/07/2026 0,4300 USD
08/05/2026 0,4300 USD
23/01/2026 0,4300 USD
07/11/2025 0,4300 USD
25/07/2025 0,4300 USD
09/05/2025 0,4300 USD
24/01/2025 0,4300 USD
08/11/2024 0,4200 USD
26/07/2024 0,4200 USD
09/05/2024 0,4200 USD
25/01/2024 0,4200 USD
09/11/2023 0,4100 USD
27/07/2023 0,4100 USD
11/05/2023 0,4100 USD
26/01/2023 0,4100 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/04/2004 34,91 35,01 34,54 34,67 -0,98% 1,36% 22.837.229
21/04/2004 34,81 35,34 34,73 35,01 +0,55% 1,74% 18.746.339
20/04/2004 35,34 35,52 34,49 34,82 -2,34% 2,93% 20.177.776
19/04/2004 35,77 35,83 35,30 35,65 -0,11% 1,49% 18.369.007
16/04/2004 35,47 35,96 35,15 35,69 +0,75% 2,27% 28.336.895
15/04/2004 34,07 35,51 34,06 35,43 +4,27% 4,26% 40.306.963
14/04/2004 33,59 34,03 33,54 33,98 +1,19% 1,47% 16.797.598
13/04/2004 34,04 34,05 33,45 33,58 -0,78% 1,76% 22.015.847
12/04/2004 33,78 33,85 33,35 33,84 +0,20% 1,49% 12.483.365
08/04/2004 34,15 34,15 33,53 33,78 -0,20% 1,81% 15.716.089
07/04/2004 33,94 34,47 33,61 33,84 -0,36% 2,52% 21.752.979
06/04/2004 33,92 34,19 33,85 33,97 -0,91% 1,01% 14.220.568
05/04/2004 34,27 34,34 33,83 34,28 +0,36% 1,47% 14.658.189
02/04/2004 34,25 34,37 33,92 34,16 +1,15% 1,33% 21.002.109
01/04/2004 33,87 33,98 33,68 33,77 +1,54% 0,87% 23.697.714
31/03/2004 33,34 33,51 33,12 33,25 -0,26% 1,17% 17.456.770
30/03/2004 33,24 33,39 32,92 33,34 +0,34% 1,40% 16.518.604
29/03/2004 32,75 33,30 32,74 33,23 +2,13% 1,71% 17.042.231
26/03/2004 32,26 32,93 32,22 32,53 -0,06% 2,21% 15.768.683
25/03/2004 32,76 32,77 32,15 32,55 +0,38% 1,88% 21.349.929
24/03/2004 32,48 32,81 32,15 32,43 +0,12% 2,02% 20.163.442
23/03/2004 32,28 32,74 32,10 32,39 +1,31% 2,00% 21.008.328
22/03/2004 32,21 32,45 31,78 31,97 -0,74% 2,06% 21.740.015
19/03/2004 32,83 33,04 32,17 32,21 -2,16% 2,63% 27.586.553
18/03/2004 32,98 33,24 32,58 32,92 -0,57% 1,99% 23.000.283
17/03/2004 33,59 33,78 32,96 33,11 -1,47% 2,43% 25.280.717
16/03/2004 33,40 33,85 33,31 33,61 +1,34% 1,62% 16.711.275
15/03/2004 33,43 33,56 32,99 33,16 -0,96% 1,70% 23.459.405
12/03/2004 33,82 33,82 33,00 33,48 +0,14% 2,44% 23.746.936
11/03/2004 34,25 34,25 33,30 33,43 -3,11% 2,77% 26.322.069